Bausch & Lomb Analyst Ratings
Bausch & Lomb Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/03/2023 | 0.48% | Barclays | $18 → $19 | Maintains | Equal-Weight |
07/24/2023 | 11.05% | RBC Capital | $20 → $21 | Maintains | Outperform |
07/10/2023 | 21.63% | Citigroup | $22 → $23 | Maintains | Buy |
07/03/2023 | 21.63% | B of A Securities | $19 → $23 | Maintains | Buy |
07/03/2023 | 16.34% | HC Wainwright & Co. | → $22 | Reiterates | Buy → Buy |
05/30/2023 | 5.76% | Morgan Stanley | → $20 | Assumes | → Equal-Weight |
05/19/2023 | 16.34% | HC Wainwright & Co. | $19 → $22 | Maintains | Buy |
05/05/2023 | 0.48% | HC Wainwright & Co. | $21 → $19 | Maintains | Buy |
05/05/2023 | -4.81% | Barclays | $17 → $18 | Maintains | Equal-Weight |
05/04/2023 | 5.76% | RBC Capital | → $20 | Reiterates | → Outperform |
03/23/2023 | 11.05% | HC Wainwright & Co. | → $21 | Reiterates | → Buy |
03/09/2023 | — | Needham | Initiates Coverage On | → Hold | |
02/24/2023 | 11.05% | HC Wainwright & Co. | $20 → $21 | Maintains | Buy |
02/23/2023 | -10.1% | JP Morgan | $15 → $17 | Maintains | Neutral |
02/23/2023 | 5.76% | Morgan Stanley | $18 → $20 | Maintains | Equal-Weight |
02/23/2023 | 5.76% | RBC Capital | → $20 | Reiterates | → Outperform |
02/15/2023 | 5.76% | RBC Capital | $17 → $20 | Maintains | Outperform |
02/02/2023 | 5.76% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
12/21/2022 | -10.1% | Barclays | → $17 | Initiates Coverage On | → Equal-Weight |
11/23/2022 | -10.1% | Goldman Sachs | $19 → $17 | Maintains | Neutral |
11/03/2022 | -20.68% | JP Morgan | $16 → $15 | Maintains | Neutral |
11/03/2022 | -10.1% | RBC Capital | $18 → $17 | Maintains | Outperform |
11/03/2022 | -4.81% | Morgan Stanley | $19 → $18 | Maintains | Equal-Weight |
11/03/2022 | 5.76% | HC Wainwright & Co. | $21 → $20 | Maintains | Buy |
10/11/2022 | 0.48% | Morgan Stanley | $20 → $19 | Maintains | Equal-Weight |
09/12/2022 | 11.05% | HC Wainwright & Co. | → $21 | Initiates Coverage On | → Buy |
08/16/2022 | 0.48% | Goldman Sachs | $22 → $19 | Maintains | Neutral |
07/26/2022 | 16.34% | RBC Capital | → $22 | Initiates Coverage On | → Outperform |
06/24/2022 | 11.05% | Evercore ISI Group | → $21 | Initiates Coverage On | → Outperform |
06/09/2022 | 5.76% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight |
06/06/2022 | 16.34% | Citigroup | → $22 | Initiates Coverage On | → Buy |
05/31/2022 | 16.34% | Morgan Stanley | → $22 | Initiates Coverage On | → Equal-Weight |
05/31/2022 | 16.34% | Goldman Sachs | → $22 | Initiates Coverage On | → Neutral |
05/31/2022 | 26.92% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
05/31/2022 | 21.63% | Wells Fargo | → $23 | Initiates Coverage On | → Overweight |
05/11/2022 | 85.09% | Cowen & Co. | → $35 | Initiates Coverage On | → Outperform |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
08/03/2023 | 0.48% | 巴克莱 | $18→$19 | 维护 | 等重 |
07/24/2023 | 11.05% | 加拿大皇家银行资本 | $20→$21 | 维护 | 跑赢大盘 |
07/10/2023 | 21.63% | 花旗集团 | $22→$23 | 维护 | 买 |
07/03/2023 | 21.63% | B of A证券 | $19→$23 | 维护 | 买 |
07/03/2023 | 16.34% | HC Wainwright公司 | →$22 | 重申 | 购买→购买 |
2023年05月30日 | 5.76% | 摩根士丹利 | →$20 | 假设 | →等重 |
2023年05月19日 | 16.34% | HC Wainwright公司 | $19→$22 | 维护 | 买 |
05/05/2023 | 0.48% | HC Wainwright公司 | $21→$19 | 维护 | 买 |
05/05/2023 | -4.81% | 巴克莱 | $17→$18 | 维护 | 等重 |
05/04/2023 | 5.76% | 加拿大皇家银行资本 | →$20 | 重申 | →跑赢大盘 |
03/23/2023 | 11.05% | HC Wainwright公司 | →$21 | 重申 | →购买 |
03/09/2023 | - | 李约瑟 | 开始承保 | →保留 | |
02/24/2023 | 11.05% | HC Wainwright公司 | $20→$21 | 维护 | 买 |
02/23/2023 | -10.1% | 摩根大通 | $15→$17 | 维护 | 中性 |
02/23/2023 | 5.76% | 摩根士丹利 | $18→$20 | 维护 | 等重 |
02/23/2023 | 5.76% | 加拿大皇家银行资本 | →$20 | 重申 | →跑赢大盘 |
02/15/2023 | 5.76% | 加拿大皇家银行资本 | $17→$20 | 维护 | 跑赢大盘 |
02/02/2023 | 5.76% | HC Wainwright公司 | →$20 | 重申 | →购买 |
2022年12月21日 | -10.1% | 巴克莱 | →$17 | 开始承保 | →等重 |
2022年11月23日 | -10.1% | 高盛 | $19→$17 | 维护 | 中性 |
11/03/2022 | -20.68% | 摩根大通 | $16→$15 | 维护 | 中性 |
11/03/2022 | -10.1% | 加拿大皇家银行资本 | $18→$17 | 维护 | 跑赢大盘 |
11/03/2022 | -4.81% | 摩根士丹利 | $19→$18 | 维护 | 等重 |
11/03/2022 | 5.76% | HC Wainwright公司 | $21→$20 | 维护 | 买 |
2022年10月11日 | 0.48% | 摩根士丹利 | $20→$19 | 维护 | 等重 |
09/12/2022 | 11.05% | HC Wainwright公司 | →$21 | 开始承保 | →购买 |
08/16/2022 | 0.48% | 高盛 | $22→$19 | 维护 | 中性 |
07/26/2022 | 16.34% | 加拿大皇家银行资本 | →$22 | 开始承保 | →跑赢大盘 |
2022/06/24 | 11.05% | Evercore ISI集团 | →$21 | 开始承保 | →跑赢大盘 |
06/09/2022 | 5.76% | 摩根士丹利 | $22→$20 | 维护 | 等重 |
06/06/2022 | 16.34% | 花旗集团 | →$22 | 开始承保 | →购买 |
2022年05月31日 | 16.34% | 摩根士丹利 | →$22 | 开始承保 | →等重 |
2022年05月31日 | 16.34% | 高盛 | →$22 | 开始承保 | →中性 |
2022年05月31日 | 26.92% | 古根海姆 | →$24 | 开始承保 | →购买 |
2022年05月31日 | 21.63% | 富国银行 | →$23 | 开始承保 | →超重 |
2022年05月11日 | 85.09% | 考恩公司 | →$35 | 开始承保 | →跑赢大盘 |
What is the target price for Bausch & Lomb (BLCO)?
博士伦的目标价是多少?
The latest price target for Bausch & Lomb (NYSE: BLCO) was reported by Barclays on August 3, 2023. The analyst firm set a price target for $19.00 expecting BLCO to rise to within 12 months (a possible 0.48% upside). 27 analyst firms have reported ratings in the last year.
巴克莱银行于2023年8月3日公布了博士伦(纽约证券交易所代码:BLCO)的最新目标价。这家分析公司将目标价定为19.00美元,预计BLCO将在12个月内上涨(可能上涨0.48%)。去年有27家分析公司公布了评级。
What is the most recent analyst rating for Bausch & Lomb (BLCO)?
博士伦(Bausch&Lomb)最近的分析师评级是多少?
The latest analyst rating for Bausch & Lomb (NYSE: BLCO) was provided by Barclays, and Bausch & Lomb maintained their equal-weight rating.
博士伦(纽约证券交易所代码:BLCO)的最新分析师评级由巴克莱提供,博士伦维持其同等权重评级。
When is the next analyst rating going to be posted or updated for Bausch & Lomb (BLCO)?
博士伦(Bausch&Lomb)的下一次分析师评级何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bausch & Lomb, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bausch & Lomb was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查看公开的财务报表,与博士伦的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。博士伦的上一次评级是在2023年8月3日提交的,因此你应该预计下一次评级将在2024年8月3日左右的某个时候公布。
Is the Analyst Rating Bausch & Lomb (BLCO) correct?
分析师对博士伦的评级正确吗?
While ratings are subjective and will change, the latest Bausch & Lomb (BLCO) rating was a maintained with a price target of $18.00 to $19.00. The current price Bausch & Lomb (BLCO) is trading at is $18.91, which is within the analyst's predicted range.
虽然评级是主观的,并将发生变化,但博士伦(BLCO)的最新评级维持不变,目标价在18.00美元至19.00美元之间。博士伦目前的股价为18.91美元,在分析师的预测区间内。